These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
271 related articles for article (PubMed ID: 18723032)
1. Epigenetic mechanisms of facioscapulohumeral muscular dystrophy. de Greef JC; Frants RR; van der Maarel SM Mutat Res; 2008 Dec; 647(1-2):94-102. PubMed ID: 18723032 [TBL] [Abstract][Full Text] [Related]
2. Specific loss of histone H3 lysine 9 trimethylation and HP1gamma/cohesin binding at D4Z4 repeats is associated with facioscapulohumeral dystrophy (FSHD). Zeng W; de Greef JC; Chen YY; Chien R; Kong X; Gregson HC; Winokur ST; Pyle A; Robertson KD; Schmiesing JA; Kimonis VE; Balog J; Frants RR; Ball AR; Lock LF; Donovan PJ; van der Maarel SM; Yokomori K PLoS Genet; 2009 Jul; 5(7):e1000559. PubMed ID: 19593370 [TBL] [Abstract][Full Text] [Related]
3. Common epigenetic changes of D4Z4 in contraction-dependent and contraction-independent FSHD. de Greef JC; Lemmers RJ; van Engelen BG; Sacconi S; Venance SL; Frants RR; Tawil R; van der Maarel SM Hum Mutat; 2009 Oct; 30(10):1449-59. PubMed ID: 19728363 [TBL] [Abstract][Full Text] [Related]
4. Genetic and epigenetic contributors to FSHD. Daxinger L; Tapscott SJ; van der Maarel SM Curr Opin Genet Dev; 2015 Aug; 33():56-61. PubMed ID: 26356006 [TBL] [Abstract][Full Text] [Related]
5. In junk we trust: repetitive DNA, epigenetics and facioscapulohumeral muscular dystrophy. Neguembor MV; Gabellini D Epigenomics; 2010 Apr; 2(2):271-87. PubMed ID: 22121874 [TBL] [Abstract][Full Text] [Related]
6. Facioscapulohumeral muscular dystrophy and DUX4: breaking the silence. van der Maarel SM; Tawil R; Tapscott SJ Trends Mol Med; 2011 May; 17(5):252-8. PubMed ID: 21288772 [TBL] [Abstract][Full Text] [Related]
8. DNA methylation analysis of the macrosatellite repeat associated with FSHD muscular dystrophy at single nucleotide level. Huichalaf C; Micheloni S; Ferri G; Caccia R; Gabellini D PLoS One; 2014; 9(12):e115278. PubMed ID: 25545674 [TBL] [Abstract][Full Text] [Related]
9. A large patient study confirming that facioscapulohumeral muscular dystrophy (FSHD) disease expression is almost exclusively associated with an FSHD locus located on a 4qA-defined 4qter subtelomere. Thomas NS; Wiseman K; Spurlock G; MacDonald M; Ustek D; Upadhyaya M J Med Genet; 2007 Mar; 44(3):215-8. PubMed ID: 16987949 [TBL] [Abstract][Full Text] [Related]
10. Intrinsic epigenetic regulation of the D4Z4 macrosatellite repeat in a transgenic mouse model for FSHD. Krom YD; Thijssen PE; Young JM; den Hamer B; Balog J; Yao Z; Maves L; Snider L; Knopp P; Zammit PS; Rijkers T; van Engelen BG; Padberg GW; Frants RR; Tawil R; Tapscott SJ; van der Maarel SM PLoS Genet; 2013 Apr; 9(4):e1003415. PubMed ID: 23593020 [TBL] [Abstract][Full Text] [Related]
11. DICER/AGO-dependent epigenetic silencing of D4Z4 repeats enhanced by exogenous siRNA suggests mechanisms and therapies for FSHD. Lim JW; Snider L; Yao Z; Tawil R; Van Der Maarel SM; Rigo F; Bennett CF; Filippova GN; Tapscott SJ Hum Mol Genet; 2015 Sep; 24(17):4817-28. PubMed ID: 26041815 [TBL] [Abstract][Full Text] [Related]
12. Interpretation of the Epigenetic Signature of Facioscapulohumeral Muscular Dystrophy in Light of Genotype-Phenotype Studies. Nikolic A; Jones TI; Govi M; Mele F; Maranda L; Sera F; Ricci G; Ruggiero L; Vercelli L; Portaro S; Villa L; Fiorillo C; Maggi L; Santoro L; Antonini G; Filosto M; Moggio M; Angelini C; Pegoraro E; Berardinelli A; Maioli MA; D'Angelo G; Di Muzio A; Siciliano G; Tomelleri G; D'Esposito M; Della Ragione F; Brancaccio A; Piras R; Rodolico C; Mongini T; Magdinier F; Salsi V; Jones PL; Tupler R Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32290091 [TBL] [Abstract][Full Text] [Related]
13. Sporadic DUX4 expression in FSHD myocytes is associated with incomplete repression by the PRC2 complex and gain of H3K9 acetylation on the contracted D4Z4 allele. Haynes P; Bomsztyk K; Miller DG Epigenetics Chromatin; 2018 Aug; 11(1):47. PubMed ID: 30122154 [TBL] [Abstract][Full Text] [Related]
14. Two Cases of Facioscapulohumeral Muscular Dystrophy 2 in Korea. Lee JH; Park HJ; Seong MW; Park SS; Choi YC Yonsei Med J; 2021 Jan; 62(1):95-98. PubMed ID: 33381940 [TBL] [Abstract][Full Text] [Related]
15. Large family cohorts of lymphoblastoid cells provide a new cellular model for investigating facioscapulohumeral muscular dystrophy. Jones TI; Himeda CL; Perez DP; Jones PL Neuromuscul Disord; 2017 Mar; 27(3):221-238. PubMed ID: 28161093 [TBL] [Abstract][Full Text] [Related]
17. Monosomy 18p is a risk factor for facioscapulohumeral dystrophy. Balog J; Goossens R; Lemmers RJLF; Straasheijm KR; van der Vliet PJ; Heuvel AVD; Cambieri C; Capet N; Feasson L; Manel V; Contet J; Kriek M; Donlin-Smith CM; Ruivenkamp CAL; Heard P; Tapscott SJ; Cody JD; Tawil R; Sacconi S; van der Maarel SM J Med Genet; 2018 Jul; 55(7):469-478. PubMed ID: 29563141 [TBL] [Abstract][Full Text] [Related]
18. The cell biology of disease: FSHD: copy number variations on the theme of muscular dystrophy. Cabianca DS; Gabellini D J Cell Biol; 2010 Dec; 191(6):1049-60. PubMed ID: 21149563 [TBL] [Abstract][Full Text] [Related]
19. Patients with a phenotype consistent with facioscapulohumeral muscular dystrophy display genetic and epigenetic heterogeneity. Sacconi S; CamaƱo P; de Greef JC; Lemmers RJ; Salviati L; Boileau P; Lopez de Munain Arregui A; van der Maarel SM; Desnuelle C J Med Genet; 2012 Jan; 49(1):41-6. PubMed ID: 21984748 [TBL] [Abstract][Full Text] [Related]
20. Does DNA Methylation Matter in FSHD? Salsi V; Magdinier F; Tupler R Genes (Basel); 2020 Feb; 11(3):. PubMed ID: 32121044 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]